This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: Enteromedics Inc., Reshape Lifesciences Inc.. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 45 
2 out of 20 Years Active: 2013-2026
Title: **Innovative Contributions of Dennis Dong-won Kim in Glucose Regulation**
Introduction
Dennis Dong-won Kim is an influential inventor based in La Jolla, California. He has made significant strides in the field of medical technology, particularly with his innovative approaches to glucose regulation. With a total of eight patents to his name, Kim's work stands out for its practical applications and potential impact on healthcare.
Latest Patents
Among his most notable patents, Dennis Kim has developed various methods and systems for glucose regulation. These innovations include unique approaches for treating conditions associated with impaired glucose regulation. One embodiment describes the application of a neural conduction block to a target nerve at a blocking site, chosen to partially block nerve pulses. Furthermore, he explores combinations of down-regulating and/or up-regulating with or without pharmaceutical agents to address impaired glucose levels. His patents also focus on the up-regulation or down-regulation of specific nerves, such as the vagus nerve and its branches, and the splanchnic nerve, which play crucial roles in modifying the production of GLP-1 and GIP hormones, thereby helping to control glucose levels.
Career Highlights
Dennis Dong-won Kim has worked with prominent companies where he leveraged his expertise in medical technology. Notably, he has been associated with Enteromedics Inc. and Reshape Lifesciences Inc., contributing to their innovation in the healthcare sector. His career is marked by a commitment to advancing technologies that enhance patient outcomes.
Collaborations
Throughout his career, Kim has collaborated with talented individuals, including Mark B. Knudson and Katherine S. Tweden. These partnerships have likely enriched his work and led to breakthroughs within the medical field.
Conclusion
In summary, Dennis Dong-won Kim is a distinguished inventor whose work in glucose regulation has the potential to transform how we understand and treat related conditions. His eight patents reflect not only his innovative mindset but also his dedication to improving health outcomes through technology. As the medical field continues to evolve, contributions from inventors like Kim will remain vital in shaping a healthier future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile